177
Views
29
CrossRef citations to date
0
Altmetric
Research Article

Risk modification by CYP1A1 and GSTM1 polymorphisms in the association of cigarette smoking and systemic lupus erythematosus in a Japanese population

, , , , , , , , & show all
Pages 103-109 | Accepted 24 Jul 2011, Published online: 04 Jan 2012

References

  • Parks CG, Cooper GS. Occupational exposures and risk of systemic lupus erythematosus: a review of the evidence and exposure assessment methods in population- and clinic-based studies. Lupus 2006;15:728–36.
  • Cooper GS, Dooley MA, Treadwell EL, St Clair EW, Parks CG, Gilkeson GS. Hormonal, environmental, and infectious risk factors for developing systemic lupus erythematosus. Arthritis Rheum 1998;41:1714–24.
  • Sanchez-Guerrero J, Karlson EW, Colditz GA, Hunter DJ, Speizer FE, Liang MH. Hair dye use and the risk of developing systemic lupus erythematosus. Arthritis Rheum 1996;39:657–62.
  • Montanaro A, Bardana EJ Jr. Dietary amino acid-induced systemic lupus erythematosus. Rheum Dis Clin North Am 1991;17:323–32.
  • Costenbader KH, Kim DJ, Peerzada J, Lockman S, Nobles-Knight D, Petri M, . Cigarette smoking and the risk of systemic lupus erythematosus: a meta-analysis. Arthritis Rheum 2004;50:849–57.
  • Jarvinen P, Aho K. Twin studies in rheumatic diseases. Semin Arthritis Rheum 1994;24:19–28.
  • Grennan DM, Parfitt A, Manolios N, Huang Q, Hyland V, Dunckley H, . Family and twin studies in systemic lupus erythematosus. Dis Markers 1997;13:93–8.
  • Deapen D, Escalante A, Weinrib L, Horwitz D, Bachman B, Roy-Burman P, . A revised estimate of twin concordance in systemic lupus erythematosus. Arthritis Rheum 1992;35:311–18.
  • Tsao BP. Update on human systemic lupus erythematosus genetics. Curr Opin Rheumatol 2004;16:513–21.
  • Washio M, Horiuchi T, Kiyohara C, Kodama H, Tada Y, Asami T, . Smoking, drinking, sleeping habits, and other lifestyle factors and the risk of systemic lupus erythematosus in Japanese females: findings from the KYSS study. Mod Rheumatol 2006;16:143–50.
  • Griffiths HR. Is the generation of neo-antigenic determinants by free radicals central to the development of autoimmune rheumatoid disease? Autoimmun Rev 2008;7:544–9.
  • Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, . The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271–7.
  • Hayashi S, Watanabe J, Nakachi K, Kawajiri K. Genetic linkage of lung cancer-associated MspI polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P450IA1 gene. J Biochem 1991;110:407–11.
  • Zhong S, Wyllie AH, Barnes D, Wolf CR, Spurr NK. Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer. Carcinogenesis 1993;14:1821–4.
  • Rothman KJ. The estimation of synergy or antagonism. Am J Epidemiol 1976;103:506–11.
  • Rothman KJ. Causes. Am J Epidemiol 1976;104:587–92.
  • Rothman KJ. Measuring interaction. Epidemiology: an introduction. New York: Oxford University Press, 2002:168–80.
  • Andersson T, Alfredsson L, Kallberg H, Zdravkovic S, Ahlbom A. Calculating measures of biological interaction. Eur J Epidemiol 2005;20:575–9.
  • Kiyohara C, Hirohata T, Inutsuka S. The relationship between aryl hydrocarbon hydroxylase and polymorphisms of the CYP1A1 gene. Jpn J Cancer Res 1996;87:18–24.
  • Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA, . Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003;349:1526–33.
  • Garte S, Gaspari L, Alexandrie AK, Ambrosone C, Autrup H, Autrup JL, . Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev 2001;10:1239–48.
  • Vineis P, Veglia F, Benhamou S, Butkiewicz D, Cascorbi I, Clapper ML, CYP1A1 T3801 C polymorphism and lung cancer: a pooled analysis of 2451 cases and 3358 controls. Int J Cancer 2003;104:650–7.
  • Rebbeck TR. Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomarkers Prev 1997;6:733–43.
  • Yen JH, Chen CJ, Tsai WC, Lin CH, Ou TT, Hu CJ, . Manganese superoxide dismutase and cytochrome P450 1A1 genes polymorphisms in rheumatoid arthritis in Taiwan. Hum Immunol 2003;64:366–73.
  • Horiuchi T, Washio M, Kiyohara C, Tsukamoto H, Tada Y, Asami T, . Combination of TNF-RII, CYP1A1 and GSTM1 polymorphisms and the risk of Japanese SLE: findings from the KYSS study. Rheumatology (Oxford) 2009;48:1045–9.
  • Landi MT, Bertazzi PA, Shields PG, Clark G, Lucier GW, Garte SJ, . Association between CYP1A1 genotype, mRNA expression and enzymatic activity in humans. Pharmacogenetics 1994;4:242–6.
  • von Schmiedeberg S, Fritsche E, Ronnau AC, Specker C, Golka K, Richter-Hintz D, . Polymorphisms of the xenobiotic-metabolizing enzymes CYP1A1 and NAT-2 in systemic sclerosis and lupus erythematosus. Adv Exp Med Biol 1999;455:147–52.
  • Zhang J, Deng J, Zhang C, Lu Y, Liu L, Wu Q, . Association of GSTT1, GSTM1 and CYP1A1 polymorphisms with susceptibility to systemic lupus erythematosus in the Chinese population. Clin Chim Acta 2010;411:878–81.
  • Hayes JD, Strange RC. Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology 2000;61:154–66.
  • Landi S. Mammalian class theta GST and differential susceptibility to carcinogens: a review. Mutat Res 2000;463:247–83.
  • Ollier W, Davies E, Snowden N, Alldersea J, Fryer A, Jones P, . Association of homozygosity for glutathione-S-transferase GSTM1 null alleles with the Ro+/La– autoantibody profile in patients with systemic lupus erythematosus. Arthritis Rheum 1996;39:1763–4.
  • Tew MB, Ahn CW, Friedman AW, Reveille JD, Tan FK, Alarcon GS, . Systemic lupus erythematosus in three ethnic groups. VIII. Lack of association of glutathione S-transferase null alleles with disease manifestations. Arthritis Rheum 2001;44:981–3.
  • Fraser PA, Ding WZ, Mohseni M, Treadwell EL, Dooley MA, St Clair EW, . Glutathione S-transferase M null homozygosity and risk of systemic lupus erythematosus associated with sun exposure: a possible gene–environment interaction for autoimmunity. J Rheumatol 2003;30:276–82.
  • Kang TY, El-Sohemy A, Comelis MC, Eny KM, Bae SC. Glutathione S-transferase genotype and risk of systemic lupus erythematosus in Koreans. Lupus 2005;14:381–4.
  • Han JW, Zheng HF, Cui Y, Sun LD, Ye DQ, Hu Z, . Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nat Genet 2009;41:1234–7.
  • Hunter DJ. Gene–environment interactions in human diseases. Nat Rev Genet 2005;6:287–98.
  • Kamataki T. Metabolism of xenobiotics. In: Omura T, Ishimura Y, Fuijii-Kuriyama Y, editors. Cytochrome P-450, 2nd edn. Tokyo, Japan: Kodansha Ltd, 1993:141–58.
  • Hayes JD, Flanagan JU, Jowsey IR. Glutathione transferases. Annu Rev Pharmacol Toxicol 2005;45:51–88.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.